RPR-115135

N/A

Report date: 2026/01/23 17:55:27

NME

Base Information

Drug NameRPR-115135

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProtein farnesyltransferase inhibitors

TargetsProtein farnesyltransferase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi Aventis

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSanofi

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A